Nebenwirkungen · Gencebok
Gencebok 10 mg/ml solution for infusion · Abschnitt 4.8 · PDF-Seite 6
HOS-147393 · Präparat HOS-099648
The adverse reactions described in the short- and long-term published literature and obtained from a post-authorisation safety study that can be associated with caffeine citrate are listed below by System Organ Class and Preferred Term (MedDRA). Frequency is defined as: very common (≥ 1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-03-12T11:47:00Z · SHA-256 6e3fcdb632e35a419e60a0205279199521acdd7f49db6bbb54b87cd49828401f · Passage b28c4ee95a95e863b92dca0ff58f762526e85294273bee8f06974dc90d5f7404 · Zeichen 584–1046 im Abschnitt